Scarica l'app Stockscreener
8.56
5.20%
-0.47
Dopo l'orario di chiusura:
8.50
-0.06
-0.70%
Neuropace Inc Borsa (NPCE) Ultime notizie
Wells Fargo & Company Has Lowered Expectations for NeuroPace (NASDAQ:NPCE) Stock Price - MarketBeat
NeuroPace (NASDAQ:NPCE) Releases Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Neuropace’s Innovative Approach to Treating Lennox-Gastaut Syndrome - TipRanks
NeuroPace, Inc. (NASDAQ:NPCE) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year - simplywall.st
NeuroPace stock price target lowered to $13 by Wolfe Research - Investing.com South Africa
AI Trend Models Suggest Bounce for NeuroPace Inc.Weekly Trading Summary & Daily Entry Point Trade Alerts - kangso.co.kr
NeuroPace Raises 2025 Revenue Guidance to $94-98 Million on Strong RNS System Sales. - AInvest
Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Cuts Target Price to $15 - 富途牛牛
Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20 - 富途牛牛
NeuroPace, Inc. (NASDAQ:NPCE) Q2 2025 Earnings Call Transcript - Insider Monkey
NeuroPace Q2 Loss Wider Than Expected, Revenue Exceeds ForecastsNews and Statistics - IndexBox
NeuroPace 2025 Q2 Earnings Revenue Growth Amid Sustained Net Loss - AInvest
NeuroPace stock price target lowered to $15 by Wells Fargo on wider loss forecast - Investing.com South Africa
NeuroPace Inc.: Q2 Earnings Snapshot - Greenwich Time
NeuroPace Expects FDA Submission for Expanded IGE Indication in 2H 2025 - AInvest
NeuroPace Q2 Revenue Hits $23.5M, Up 22% YoY, With Gross Margin at 77.1% - AInvest
NeuroPace Inc (NPCE) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
NeuroPace Reports Record Revenue and Raises Guidance - TipRanks
Is NeuroPace Inc. in Accumulation Phase NowAI Based High Gain Watchlist Scanner Shared - beatles.ru
NeuroPace Q2 2025 Earnings Call Transcript - MarketBeat
NeuroPace raises 2025 revenue guidance to $94M-$98M as RNS System drives record growth - MSN
NeuroPace: Building a Durable Moat in Epilepsy Treatment with AI-Driven Innovation and Expanding Indications - AInvest
NeuroPace Revenue Jumps 22 Percent in Q2 - Nasdaq
NeuroPace Raises 2025 Revenue Guidance to $94M-$98M, Driven by RNS System Growth - AInvest
NeuroPace's Q2 2025 Earnings Call: Unraveling Key Contradictions in Growth, Margins, and Strategy - AInvest
NeuroPace, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:NPCE) - Seeking Alpha
Transcript : NeuroPace, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
NeuroPace's (NPCE) Q2 Performance: A Miss on Earnings, but a Win for the Future? - AInvest
NeuroPace (NPCE) Q2 2025 Earnings Call Transcript - AOL.com
NeuroPace Achieves Record Q2 Revenue, Raises Full-Year Outlook to $94-$98 Million - AInvest
NeuroPace Outpaces Expectations Thanks To RNS System Sales - Finimize
Earnings call transcript: Neuropace Q2 2025 sees revenue rise; stock gains 2.7% - Investing.com Canada
NeuroPace Reports Record Q2 Revenue - AOL.com
NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
NeuroPace Inc SEC 10-Q Report - TradingView
Neuropace Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Neuropace earnings missed by $0.04, revenue topped estimates - Investing.com Canada
NeuroPace's Q2 2025 Earnings: A Tale of Two Metrics and the Road to Long-Term Growth - AInvest
NeuroPace Reports Record Q2 2025 Revenue of $23.5 Million, Increases 2025 Guidance - AInvest
NeuroPace Q2 revenue $23.5mln, up 22% YoY, raises FY25 guidance to $94-$98mln. - AInvest
NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - GlobeNewswire
Can NeuroPace Inc. sustain earnings growthBottom Fishing Opportunity - newsyoung.net
NeuroPace Receives Buy Rating from Lake Street Analyst - AInvest
Is NeuroPace Inc. the Top Chart Pick This WeekTrend Analysis for Safer Trades Gains Popularity - sundaytimes.kr
What risks could impact NeuroPace Inc. stock performanceShort Term Momentum Based Trading Strategy - Newser
Applying chart zones and confluence areas to NeuroPace Inc.Free Community Verified Stock Suggestions - Newser
What the charts say about NeuroPace Inc. todayWatchlist Summary for Active Day Traders - Newser
Will NeuroPace Inc. bounce back from current supportHigh Win Rate Strategy with Stop Protection - Newser
Technical signs of recovery in NeuroPace Inc.Daily Market Movers Screener with Filters - Newser
Is a relief rally coming for NeuroPace Inc. holdersFree Triple Return Setup with Risk Control - Newser
News impact scoring models applied to NeuroPace Inc.Swing Trade Timing with Daily Forecast - Newser
NeuroPace (NPCE) to Release Earnings on Tuesday - Defense World
NeuroPace (NPCE) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
What earnings revisions data tells us about NeuroPace Inc.Equity Market Return Forecast Model Update - Newser
Neuropace Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Bank of New York Mellon Corp Sells 1,437 Shares of NeuroPace, Inc. (NASDAQ:NPCE) - Defense World
How does NeuroPace Inc. compare to its industry peersTake advantage of unprecedented market momentum - Jammu Links News
What makes NeuroPace Inc. stock price move sharplyExceptional financial outcomes - Jammu Links News
1.74%
0.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):